pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,153 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 29 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: phase readout×type: approval×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›COMPLETEDphase readoutNCT00980538: TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants

    Sponsor: Janssen Sciences Ireland UC. Phase: PHASE3. Conditions: HIV Infections, HIV-1

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03229538: STeroids to REduce Systemic Inflammation After Infant Heart Surgery

    Sponsor: Kevin Hill. Phase: PHASE3. Conditions: Congenital Heart Disease in Children, Inflammatory Response

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06301438: Dalpiciclib in HR+/HER2- ABC

    Sponsor: RenJi Hospital. Phase: . Conditions: Advanced Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06896838: Comparison of Intercostal and Quadriceps Femoris Muscle Oxygenation in Women and Men

    Sponsor: Kirsehir Ahi Evran Universitesi. Phase: . Conditions: Near-Infrared Spectroscopy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07032038: First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant

    Sponsor: Rinri Therapeutics. Phase: PHASE1. Conditions: Sensorineural Hearing Loss, Presbyacusis, Auditory Neuropathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07255638: A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany

    Sponsor: Blueprint Medicines Corporation. Phase: . Conditions: Indolent Systemic Mastocytosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06671938: Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

    Sponsor: BioArctic AB. Phase: PHASE2. Conditions: Parkinson Disease, Multiple System Atrophy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06682858: Developing a Novel Therapy for Aversive Sensory Experiences in Autism

    Sponsor: King's College London. Phase: NA. Conditions: Autism, Autism in Children

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07551258: Innate Immune Immunoparalysis and Ventilator-Associated Pneumonia in Critically Ill Elderly Patients

    Sponsor: Hospital Universitari de Bellvitge. Phase: . Conditions: Intubated ICU Patients, Ventilator Associated Pneumonia ( VAP), Immunoparalysis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04969926: Natural History Study of Parathyroid Disorders

    Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Parathyroid Cancer, Primary Hyperparathyroidism, Pseudohypoparathyroidism, Inheritable Bone Diseases, Multiple Endocrine Neoplasia, Type 1

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07575126: Comparison of Qigong and Otago in Patient With Diabetic Neuropathy

    Sponsor: Riphah International University. Phase: NA. Conditions: Diabetic Neuropathies

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06194799: ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

    Sponsor: ACADIA Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Alzheimer's Disease Psychosis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07339098: Efficacy and Safety of the Ultrasound Stimulation Device NEFRONIX in Patients With Chronic Kidney Disease

    Sponsor: Anasonic. Phase: NA. Conditions: Chronic Kidney Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06906263: Complications Related to the Anaesthesia During Airway Endoscopy in Children With Tracheostomy.

    Sponsor: Karolinska Institutet. Phase: . Conditions: Anesthesia Complication, Tracheostomy Complications, Children Receiving General Anesthesia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00457587: Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma

    Sponsor: University of Wuerzburg. Phase: . Conditions: Adrenocortical Carcinoma, Cushing's Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03713593: Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Carcinoma, Hepatocellular

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02281916: Safety Study of P28GST Treatment in Crohn's Disease Patients

    Sponsor: University Hospital, Lille. Phase: PHASE2. Conditions: Crohn's Ileocolitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02821806: Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Healthy Volunteer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07564206: Foam Roller Compared to Massage on Reducing Calf Muscle Tone in Healthy Subjects

    Sponsor: Universidad Europea de Madrid. Phase: NA. Conditions: Muscle Tone, Healthy Adult

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07596004: COMPARISON OF DEXMEDETOMIDINE AND NORMAL SALINE IN NEBULIZATION TO BLUNT HEMODYNAMIC RESPONSE

    Sponsor: Shaheed Mohtarma Benazir Bhutto Institue of Trauma. Phase: NA. Conditions: HEMODYNAMIC RESPONSETO LYRANGOSCOPY AND ENDOTRACHEAL INTUBATION

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06118333: A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)

    Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Nasopharyngeal Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06740084: African Youth in Mind (Y-MIND) - Pilot Feasibility Trial of a Brief Psychological Intervention for Older Adolescents With Depression Delivered Through Senior High Schools in Navrongo, Ghana

    Sponsor: King's College London. Phase: NA. Conditions: Depression Disorders

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05983133: A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors

    Sponsor: Seagen, a wholly owned subsidiary of Pfizer. Phase: PHASE1. Conditions: Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Pancreatic Ductal Adenocarcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06154252: RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

    Sponsor: Cabaletta Bio. Phase: PHASE2. Conditions: Idiopathic Inflammatory Myopathy, Dermatomyositis, Anti-Synthetase Syndrome, Immune-Mediated Necrotizing Myopathy, Juvenile Dermatomyositis, Juvenile Polymyositis, Juvenile Idiopathic Inflammatory Myopathy (JIIM), Juvenile Myositis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04009447: Sleep Quality and Mechanisms of Cardiovascular Risks in Adults With Hypertension

    Sponsor: Duke University. Phase: NA. Conditions: Hypertension, Insomnia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07519447: Gastric Residual Volume and Aspiration Risk Following Intravenous Metoclopramide in Fasted Diabetic Patients Undergoing Elective Surgery

    Sponsor: Kafrelsheikh University. Phase: . Conditions: Gastric Residual Volume, Aspiration Risk, Metoclopramide, Fasted Diabetic Patients, Elective Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07509749: Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease)

    Sponsor: Daihong Liu. Phase: PHASE2. Conditions: GVHD, Acute, Stem Cell Transplant Complications

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03653858: Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression

    Sponsor: University Hospital Freiburg. Phase: NA. Conditions: Treatment-resistant Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07640555: Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies

    Sponsor: MODAG GmbH. Phase: EARLY_PHASE1. Conditions: Multiple System Atrophy (MSA), Healthy Adult, Parkinson Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05632055: miRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes Prediction

    Sponsor: Chiang Mai University. Phase: . Conditions: Gestational Diabetes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03818178: Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Insulin Resistance

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07582185: Tdose Binding and Tocilizumab

    Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE4. Conditions: Rheumatoid Arthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05694715: Combination Therapy in Cancers With Mutations in DNA Repair Genes

    Sponsor: University of California, San Francisco. Phase: PHASE1. Conditions: Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation, ATM Gene Mutation, PALB2 Gene Mutation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03655015: Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

    Sponsor: The University of Texas Health Science Center at San Antonio. Phase: . Conditions: Lung Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04206215: Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

    Sponsor: Spaulding Rehabilitation Hospital. Phase: NA. Conditions: Chronic Pain, Carpal Tunnel Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07430735: BriTer Eyez Moisture Vue™ On-Demand Disposable Moisture Chamber

    Sponsor: University of Rochester. Phase: NA. Conditions: Dry Eye Disease (DED)

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05845125: Evolution of Post-Stroke Shoulder Pain With a Capsular Pattern With Physiotherapy Alone Versus Coupled With Mild Arthrographic Distension With Cortisone

    Sponsor: Claire Bourgeois. Phase: PHASE4. Conditions: Shoulder Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04307576: A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

    Sponsor: Mats Heyman. Phase: PHASE3. Conditions: Leukemia, Acute Lymphoblastic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06051617: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

    Sponsor: Gilead Sciences. Phase: PHASE3. Conditions: Primary Biliary Cholangitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06127589: The "Quit-for-Kids" Project: to Increase Abstinence and Protect Children From Tobacco Smoke Exposure

    Sponsor: The University of Hong Kong. Phase: NA. Conditions: Smoking Cessation, Second Hand Tobacco Smoke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06539650: Neural Adaptations to a Single Session of Metronome-Paced Strength Training

    Sponsor: Egas Moniz - Cooperativa de Ensino Superior, CRL. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06496750: Ketamine for Methamphetamine Use Disorder

    Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE2. Conditions: Substance Use Disorders, Substance Use, Methamphetamine Abuse

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02047591: Study of a Therapy Without Drugs, Supplementary to an Usual Treatment for the Pains Caused by Removing the Redon's Drain From a 7 to 17 Years Old Child in Pediatric Surgery.

    Sponsor: University Hospital, Limoges. Phase: NA. Conditions: Surgical Operation With the Settle of a Redon's Drain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06440174: Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)

    Sponsor: University Hospital Southampton NHS Foundation Trust. Phase: . Conditions: Oesophageal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07114874: NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

    Sponsor: Neurocrine Biosciences. Phase: PHASE3. Conditions: Schizophrenia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07627490: The Potential of Transcutaneous Electrical Nerve Stimulation to Improve Pain Experienced During Posterior Branch Blocks in Patients With Lumbar Posterior Joint Syndrome

    Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Lower Back Pain Chronic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06349213: Uncovering the Cognitive and Neural Mechanisms Underlying Cognitive Time

    Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Healthy Aging

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06561360: A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Hairy Cell Leukemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07597720: Strengthening Children's Coordination and Balance in Everyday Life

    Sponsor: University of Applied Sciences for Health Professions Upper Austria. Phase: NA. Conditions: Physical Functional Performance, Physical Education and Training/Methods, Postural Balance, Child

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07193420: Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: GVHD - Graft-Versus-Host Disease, HSCT, Haploidentical Stem Cell Transplantation

    full page →ctgov ↗
    ← prev
    page 61 of 104
    next →